Zhao J - Search Results

1

Advances in neuroendocrine prostate cancer research: From model construction to molecular network analyses.

Shui X, Xu R, Zhang C, Meng H, Zhao J, Shi C. Shui X, et al. Among authors: zhao j. Lab Invest. 2022 Apr;102(4):332-340. doi: 10.1038/s41374-021-00716-0. Epub 2021 Dec 22. Lab Invest. 2022. PMID: 34937865 Free article. Review.

2

Strategies for the Construction of Mouse Models With Humanized Immune System and Evaluation of Tumor Immune Checkpoint Inhibitor Therapy.

Guo W, Zhang C, Qiao T, Zhao J, Shi C. Guo W, et al. Among authors: zhao j. Front Oncol. 2021 Apr 29;11:673199. doi: 10.3389/fonc.2021.673199. eCollection 2021. Front Oncol. 2021. PMID: 33996603 Free PMC article. Review.

3

Monoamine oxidase A drives neuroendocrine differentiation in prostate cancer.

Shui X, Ren X, Xu R, Xie Q, Hu Y, Qin J, Meng H, Zhang C, Zhao J, Shi C. Shui X, et al. Among authors: zhao j. Biochem Biophys Res Commun. 2022 May 28;606:135-141. doi: 10.1016/j.bbrc.2022.03.096. Epub 2022 Mar 23. Biochem Biophys Res Commun. 2022. PMID: 35349822

4

Monoamine oxidase A (MAOA): A promising target for prostate cancer therapy.

Han H, Li H, Ma Y, Zhao Z, An Q, Zhao J, Shi C. Han H, et al. Among authors: zhao z, zhao j. Cancer Lett. 2023 Jun 1;563:216188. doi: 10.1016/j.canlet.2023.216188. Epub 2023 Apr 17. Cancer Lett. 2023. PMID: 37076041 Review.

5

Interaction between the EPHB2 receptor and EFNB1 ligand drives gastric cancer invasion and metastasis via the Wnt/β-catenin/FAK pathway.

Hu Y, Xie Q, Zhao J, Yang R, Qin J, Li H, Zhao Y, Du X, Shi C. Hu Y, et al. Among authors: zhao j, zhao y. Int J Biol Macromol. 2024 Feb;258(Pt 1):128848. doi: 10.1016/j.ijbiomac.2023.128848. Epub 2023 Dec 17. Int J Biol Macromol. 2024. PMID: 38114003

6

[Progress in targeted inhibition of aerobic glycolysis combined with immunotherapy for renal cell carcinoma].

Zhang K, Ru M, Wang J, Zhao J, Shen L. Zhang K, et al. Among authors: zhao j. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024 Jan;40(1):74-79. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024. PMID: 38246180 Chinese.

7

Synergistic inhibition of the growth of MDA-MB-231 cells in triple-negative breast cancer by salinomycin combined with 17-AAG and its mechanism.

He D, Wu B, Du J, Li L, Zhao J. He D, et al. Among authors: zhao j. Oncol Lett. 2022 Apr;23(4):138. doi: 10.3892/ol.2022.13258. Epub 2022 Mar 1. Oncol Lett. 2022. PMID: 35317027 Free PMC article.

8

Cancer stem cell fate determination: mito-nuclear communication.

Fan M, Shi Y, Zhao J, Li L. Fan M, et al. Among authors: zhao j. Cell Commun Signal. 2023 Jun 27;21(1):159. doi: 10.1186/s12964-023-01160-x. Cell Commun Signal. 2023. PMID: 37370081 Free PMC article. Review.

9

Mitochondrial DNA methylation is a predictor of immunotherapy response and prognosis in breast cancer: scRNA-seq and bulk-seq data insights.

Ma Y, Du J, Chen M, Gao N, Wang S, Mi Z, Wei X, Zhao J. Ma Y, et al. Among authors: zhao j. Front Immunol. 2023 Jun 29;14:1219652. doi: 10.3389/fimmu.2023.1219652. eCollection 2023. Front Immunol. 2023. PMID: 37457713 Free PMC article.

10

Inhibition of FSP1: A new strategy for the treatment of tumors (Review).

Dai Q, Wei X, Zhao J, Zhang D, Luo Y, Yang Y, Xiang Y, Liu X. Dai Q, et al. Among authors: zhao j. Oncol Rep. 2024 Aug;52(2):105. doi: 10.3892/or.2024.8764. Epub 2024 Jun 28. Oncol Rep. 2024. PMID: 38940330 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57,737 results

Search Page

Filters